Nyenburgh Investment Partners
1
3M
1
0.12
1
1
- Areas of investment
Summary
Nyenburgh Investment Partners is the famous VC, which was founded in 2013. The main office of represented VC is situated in the Amsterdam. The company was established in Europe in The Netherlands.
The typical case for the fund is to invest in rounds with 1 participant. Despite the Nyenburgh Investment Partners, startups are often financed by Vinnova, U.S. Department of Defense, Congressionally Directed Medical Research Programs.
The overall number of key employees were 2.
The important activity for fund was in 2019. The increased amount of exits for fund were in 2013. The fund is constantly included in less than 2 investment rounds annually. The usual things for fund are deals in the range of 1 - 5 millions dollars.
We can highlight the next thriving fund investment areas, such as Clinical Trials, Biotechnology. Besides, a startup needs to be aged 16-20 years to get the investment from the fund. Among the most popular portfolio startups of the fund, we may highlight NeuroVive Pharmaceutical. For fund there is no match between the country of its foundation and the country of its the most frequent investments - Sweden.
Investments analytics
Analytics
- Total investments
- 1
- Lead investments
- 1
- Exits
- 1
- Rounds per year
- 0.12
- Investments by industry
- Health Care (1)
- Biotechnology (1)
- Clinical Trials (1)
- Investments by region
-
- Sweden (1)
- Peak activity year
- 2019
Discover reliable insights
Leverage validated data, identify key contacts and secure funding opportunities for your business.Quantitative data
- Avg. startup age at the time of investment
- 21
Need more data?
Get access to full data about investors, including their team, contact information, and historic data.
Latest deals
| Company name | Deal date | Industry | Deal stage | Deal size | Location |
|---|
At Unicorn Nest, we combine cutting-edge technology with human expertise to build one of the most reliable venture capital databases in the market. Our process begins with automated AI-enhanced data collection, leveraging the full potential of Large Language Models (LLMs).
Later, our team of analysts takes it further with manual verification, using proprietary tools for data cleaning and validation to ensure accuracy and reliability. We cross-check and enhance our findings through press and media monitoring, integrating information from trusted news outlets and venture capital aggregators. Finally, we stay ahead of the curve by monitoring social networks like LinkedIn and X.com.